1DEI
DESHEPTAPEPTIDE (B24-B30) INSULIN
Summary for 1DEI
Entry DOI | 10.2210/pdb1dei/pdb |
Descriptor | INSULIN (3 entities in total) |
Functional Keywords | hormone, glucose metabolism |
Biological source | Sus scrofa (pig) More |
Cellular location | Secreted: P01315 |
Total number of polymer chains | 4 |
Total formula weight | 9863.25 |
Authors | Bao, S.-J.,Chang, W.-R.,Wan, Z.-L.,Zhang, J.-P.,Liang, D.-C. (deposition date: 1996-05-15, release date: 1997-06-16, Last modification date: 2024-11-13) |
Primary citation | Bao, S.J.,Xie, D.L.,Zhang, J.P.,Chang, W.R.,Liang, D.C. Crystal structure of desheptapeptide(B24-B30)insulin at 1.6 A resolution: implications for receptor binding. Proc.Natl.Acad.Sci.USA, 94:2975-2980, 1997 Cited by PubMed Abstract: The crystal structure of desheptapeptide (B24-B30) insulin (DHPI), a virtually inactive analog of insulin, was determined at 1.6 A resolution. In the refined structure model, DHPI retains three alpha-helices (A1-A8, A12-A18, and B9-B19) as its structural framework, while great conformational changes occur in the N and C termini of B-chain. The beta-turn, which lies in B20-B30 in insulin and insulin analogs with high potency, no longer exists in DHPI. Relative motion is observed among the three alpha-helices, each as a rigid functional group. In contrast, a region covering B5-B6 and A6-A11 exhibits a relatively stable conformation. We interpret our results as identifying: (i) the importance of beta-turn in determining the receptor-binding potency of insulin and (ii) a leading role of PheB24 in maintaining the beta-turn structure. PubMed: 9096331DOI: 10.1073/pnas.94.7.2975 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report
